Acitretin delivers quicker symptom relief and is more potent, making it ideal for acute conditions. Clinical studies show that it often produces a higher response rate than Cholestyramine, making it the preferred option for fast results.

Both Acitretin and Cholestyramine have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Acitretin has a lower risk of dependency, making it a safer option for patients concerned about addiction.

Both Acitretin and Cholestyramine are easy to use, with straightforward dosing regimens that ensure good adherence.

Acitretin has fewer contraindications, making it suitable for a broader range of patients, including those with comorbidities.

Both drugs offer advantages depending on treatment goals. Acitretin is great for fast relief, while Cholestyramine is better for long-term management. The choice depends on the patient’s specific needs.